Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.

@article{Noh2009ClinicalCO,
  title={Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.},
  author={Jaeduk Yoshimura Noh and Shigemitu Yasuda and Shotaro Sato and Masako Matsumoto and Yo Kidokoro Kunii and Yoshihiko Noguchi and Koji Mukasa and Kunihiko Ito and K Ito and Osamu Sugiyama and Hiroshi Kobayashi and Shigeru Nihojima and Masaru Okazaki and Shunji Yokoyama},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2009},
  volume={94 8},
  pages={
          2806-11
        }
}
CONTEXT The clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis caused by antithyroid drugs are still unclear because most reports describe only a small number of patients. OBJECTIVE The objective was to analyze a large number of patients with MPO-ANCA-associated vasculitis to determine the time of onset, the drug and dose taken, the clinical symptoms, the relationship between the clinical symptoms and the MPO-ANCA titer, and the… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Methimazole‐induced ANCA‐associated vasculitis with diffuse alveolar haemorrhage

  • Respirology case reports
  • 2018
VIEW 7 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016

  • Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
  • 2017

Similar Papers

Loading similar papers…